Skip to main content

Intelligent cancer therapy with synthetic biology methods

Project description

Innovative approach to fighting cancer via synthetic circuits

While immunotherapy has become an important part of treating some types of cancer in the last few decades, surgery, radiotherapy or chemotherapy, alone or in combination, remain the most common interventions. The EU-funded InCanTeSiMo project aims to fight cancer via the local delivery and activation of cancer-defeating synthetic circuits. The synthetic circuits will sense the status of the cell into which they are delivered and act only in response to a detected diseased status. This innovative cancer therapy can be adapted to each patient's particular case when the synthetic circuits are being designed.

Host institution

ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Net EU contribution
€ 2 000 000,00
Address
Fahnenbergplatz
79098 Freiburg
Germany

See on map

Region
Baden-Württemberg Stuttgart Stuttgart, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Beneficiaries (1)

ALBERT-LUDWIGS-UNIVERSITAET FREIBURG
Germany
Net EU contribution
€ 2 000 000,00
Address
Fahnenbergplatz
79098 Freiburg

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Baden-Württemberg Stuttgart Stuttgart, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00